Medicare News and Research RSS Feed - Medicare News and Research Twitter

GeneSight test better predicts antidepressant outcomes for patients with depression

GeneSight test better predicts antidepressant outcomes for patients with depression

The combinatorial, multi-gene GeneSight test has been found to better predict antidepressant treatment outcomes for patients with depression, and their use of health care resources, than any of the individual genes that comprise the test, according to a peer-reviewed analysis by investigators from the Mayo Clinic and Assurex Health, and published online by The Pharmacogenomics Journal. [More]
Prime Therapeutics recognized with PBMI's 2015 Rx Innovation Award

Prime Therapeutics recognized with PBMI's 2015 Rx Innovation Award

Prime Therapeutics LLC received the Pharmacy Benefit Management Institute's 2015 Rx Innovation Award today in recognition of its innovative "Specialty Drug Watch List." [More]
New report: Prevalence of CKD in the U.S. projected to increase 16.7% by 2030

New report: Prevalence of CKD in the U.S. projected to increase 16.7% by 2030

The prevalence of chronic kidney disease (CKD) will rise in the United States, according to a new report led by RTI International and published in the American Journal of Kidney Diseases during March's National Kidney Month. [More]
Study: African Americans who moved from the South during Great Migration face shorter life expectancy

Study: African Americans who moved from the South during Great Migration face shorter life expectancy

Millions of African Americans moved from the South in the early 20th century to seek better job opportunities and higher wages, but a new study on the historic Great Migration shows that with improved economic conditions came a greater risk of mortality. [More]
Medicare Part D, adherence can help save patients with high cholesterol

Medicare Part D, adherence can help save patients with high cholesterol

According to the Centers for Disease Control and Prevention, one in three American adults has high cholesterol. For those struggling with high cholesterol, getting needed prescriptions and adhering to the prescribed treatment regimen is critical. [More]
Insurance status linked to patient safety, quality of care for patients with brain tumors

Insurance status linked to patient safety, quality of care for patients with brain tumors

Patients that are on Medicaid or uninsured have higher rates of reportable patient safety and quality of care issues during hospitalization for brain tumors, reports a study in the March issue of Neurosurgery, official journal of the Congress of Neurological Surgeons. [More]
Majority of ACS NSQIP hospitals improve surgical outcomes over time

Majority of ACS NSQIP hospitals improve surgical outcomes over time

The majority of hospitals participating in the American College of Surgeons National Surgical Quality Improvement Project improve surgical outcomes over time, and improvement continues with each year that hospitals participate in the program, according to a new study published online today in Annals of Surgery. [More]
North Memorial Medical Center receives Healthgrades 2015 America's 50 Best Hospitals Award

North Memorial Medical Center receives Healthgrades 2015 America's 50 Best Hospitals Award

Today, North Memorial Medical Center announced that it has received the Healthgrades 2015 America's 50 Best Hospitals Award. The distinction makes North Memorial Medical Center one of the top 1% of more than 4,500 hospitals nationwide for its consistent, year-over-year superior clinical performance as measured by Healthgrades, the leading online resource for comprehensive information about physicians and hospitals. [More]
Nurtur earns Wellness and Health Promotion Accreditation from NCQA for wellness services

Nurtur earns Wellness and Health Promotion Accreditation from NCQA for wellness services

Centene Corporation today announced that Nurtur, its health and wellness company serving employers, health plans and government programs, has received a three-year Wellness and Health Promotion Accreditation renewal from the National Committee for Quality Assurance for its wellness services. [More]
Regeneron announces EU approval of EYLEA (aflibercept) Injection for retinal vascular disease treatment

Regeneron announces EU approval of EYLEA (aflibercept) Injection for retinal vascular disease treatment

Regeneron Pharmaceuticals, Inc. today announced that EYLEA (aflibercept) Injection has been approved by the European Commission for the treatment of visual impairment due to Macular Edema secondary to Retinal Vein Occlusion (RVO). [More]
MiMedx Group reports record revenue of $118.2 million for full year 2014

MiMedx Group reports record revenue of $118.2 million for full year 2014

MiMedx Group, Inc., the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spinal, Sports Medicine, Ophthalmic and Dental sectors of healthcare, announced today its record results for the fourth quarter and full year ended December 31, 2014. [More]
Nuo Therapeutics initiates phase 4 study of Aurix™ under CMS coverage with evidence development program

Nuo Therapeutics initiates phase 4 study of Aurix™ under CMS coverage with evidence development program

Nuo Therapeutics, Inc. (OTCQX:NUOT), a pioneer in biodynamic therapies, today announced the initiation of a new clinical study (Au Study) that is comprised of three randomized controlled protocols that examine the efficacy of Aurix™, a biodynamic hematogel, for use in diabetic foot ulcers, venous leg ulcers and pressure ulcers (bed sores). [More]
Johns Hopkins researcher helps discover effectiveness of three drugs for treating patients with DME

Johns Hopkins researcher helps discover effectiveness of three drugs for treating patients with DME

A researcher from Johns Hopkins Medicine helped lead colleagues from across the country in a government-sponsored study by the Diabetic Retinopathy Clinical Research Network to discover that three drugs -- Eylea, Avastin and Lucentis -- used to treat diabetic macular edema are all effective. They also discovered that Eylea outperformed the other two drugs when vision loss was moderate to severe. [More]
Johns Hopkins study shows value follow-up PET/CT scans in patients with lung cancer

Johns Hopkins study shows value follow-up PET/CT scans in patients with lung cancer

New research from Johns Hopkins School of Medicine reveals a high value of scans which could lead to future change of reimbursement policies for follow-up positron emission tomography/computed tomography (PET/CT) studies in lung cancer. The study, featured in the February 2015 issue of the Journal of Nuclear Medicine, establishes the value of fourth and subsequent follow-up PET/CT scans in clinical assessment and management change in patients with the disease. [More]
Leaf Healthcare's wireless patient monitoring system can improve pressure ulcer prevention processes

Leaf Healthcare's wireless patient monitoring system can improve pressure ulcer prevention processes

Clinicians from the Veterans Affairs Medical Center in Boise, Idaho, will demonstrate that Leaf Healthcare's new, wireless patient monitoring system can significantly improve a caregiver's pressure ulcer prevention processes. Their presentation will take place at the National Pressure Ulcer Advisory Panel Biennial Conference in Orlando, Fla., this week. [More]
New study demonstrates cost-saving, health care quality outcomes of pediatric ACO

New study demonstrates cost-saving, health care quality outcomes of pediatric ACO

A new study published in Pediatrics demonstrates the cost-saving and health care quality outcomes of the pediatric Accountable Care Organization Partners for Kids. Results of this study indicate that Partners for Kids successfully improved the value of pediatric healthcare over time through cost containment, while maintaining quality of care. [More]
DaVita HealthCare Partners announces financial results for fourth quarter 2014

DaVita HealthCare Partners announces financial results for fourth quarter 2014

DaVita HealthCare Partners Inc. today announced results for the quarter and year ended December 31, 2014. Income from continuing operations attributable to DaVita HealthCare Partners Inc. for the quarter and year ended December 31, 2014 was $208 million and $723 million, or $0.96 and $3.33 per share, respectively. [More]
Gift of Hope Organ & Tissue Donor Network saves record number of lives in 2014

Gift of Hope Organ & Tissue Donor Network saves record number of lives in 2014

February 14th is National Donor Day. To celebrate, Gift of Hope Organ & Tissue Donor Network announced a record number of lives saved by helping 334 donors and their families donate 1,020 organs to patients waiting for a transplant, giving them a second chance at life last year. [More]
AMGA submits comment letter to CMS regarding proposed rule on Medicare Shared Savings Program

AMGA submits comment letter to CMS regarding proposed rule on Medicare Shared Savings Program

On Friday, the American Medical Group Association (AMGA) drafted and submitted a comment letter to the Centers for Medicare and Medicaid Services (CMS) regarding the proposed rule on refinements to the current framework of the Medicare Shared Savings Program. [More]
Experts question use of hospital quality measures in CMS’ pay-for-performance programs

Experts question use of hospital quality measures in CMS’ pay-for-performance programs

A new editorial published in JAMA by Northwestern Medicine® experts strongly questions the use of several hospital quality measures by the Centers for Medicare & Medicaid Services (CMS) in its pay-for-performance programs. [More]